Can Re-CTURBT Be Useful in pT1HG Disease As a Risk Indicator of Recurrence and Progression? A Single Centre Experience. Arch Ital Urol Androl 2017, 89 (4), 272-276. https://doi.org/10.4081/aiua.2017.4.272.